RPS19P7

Across TCGA pan-cancer cohorts, RPS19P7 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPS19P7 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS19P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS19P7 expression acts as an unfavorable survival marker, although some lineages such as KIRC and COAD show a favorable association.

ACC, LIHC, and KIRP are the cancer types where RPS19P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.626	0.954	<.001	105	view →
LIHC	OS	Median	All	0.437	0.649	<.001	55	view →
KIRP	OS	Quartile	All	0.547	0.865	.003	41	view →
KIRC	DFS	Tertile	III,IV	0.773	0.563	.017	32	view →
COAD	DFS	Tertile	All	0.704	0.407	<.001	30	view →
UVM	DFS	Quartile	III,IV	0.788	0.055	.006	26	view →
LUAD	OS	Quartile	III,IV	0.358	0.740	.004	25	view →
THYM	DFS	Tertile	All	1.000	0.541	.001	21	view →
SKCM	OS	Tertile	III,IV	0.671	0.310	.009	16	view →
OV	OS	Quartile	III,IV	0.629	0.733	.026	10	view →
PAAD	OS	Quartile	II,III,IV	0.806	0.392	.016	6	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPS19P7–ACC (OS)

Open the ACC breakdown →